SCHEMBL1720943

SCHEMBL1720943

C=Cc1cccc(C(=O)CC(=O)c2ccccc2)c1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 4/20 0.59
HPGD P15428 4/20 0.59
KMT2A Q03164 4/20 0.59
MAPT P10636 3/20 0.59
MAPK1 P28482 3/20 0.59
CYP3A4 P08684 2/20 0.59
ALOX15 P16050 2/20 0.59
SMN1; SMN2 Q16637 2/20 0.59
KDM4E B2RXH2 2/20 0.59
CES1 P23141 1/20 0.59
TDP1 Q9NUW8 1/20 0.59
NPC1 O15118 4/20 0.49
ALDH1A1 P00352 3/20 0.49
PLOD2 O00469 2/20 0.49
RAB9A P51151 2/20 0.49
HIF1A Q16665 2/20 0.49
PLOD3 O60568 1/20 0.49
CYP1A2 P05177 1/20 0.49
CYP2D6 P10635 1/20 0.49
CYP2C9 P11712 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5873228 0.88 HPGD (0.61) MEN1HPGDKMT2AMAPTMAPK1
SCHEMBL5873182 0.84 HPGD (0.65) MEN1HPGDKMT2AMAPTMAPK1
SCHEMBL4834885 0.81 MEN1 (0.81) MEN1HPGDKMT2AMAPTMAPK1
SCHEMBL29838103 0.81 GSK3B (0.52) TDP1PTPN1UNGTP53GSK3B
SCHEMBL9720583 0.81 TDP1 (0.46) MEN1HPGDKMT2AMAPTSMN1; SMN2
SCHEMBL25031282 0.81 GSK3B (0.52) TDP1PTPN1UNGTP53GSK3B
SCHEMBL25031506 0.81 ALDH1A1 (0.52) MEN1KMT2AMAPK1KDM4ETDP1
SCHEMBL29838127 0.81 ALDH1A1 (0.52) MEN1KMT2AMAPK1KDM4ETDP1
SCHEMBL1941954 0.80 ATM (0.63) MEN1HPGDKMT2AMAPTMAPK1
SCHEMBL30502883 0.80 ATM (0.63) MEN1HPGDKMT2AMAPTMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021131395-A1 ADHESIVE AGENT COMPOSITION, LAYERED BODY, METHOD FOR PRODUCING LAYERED BODY, AND METHOD FOR PRODUCING ELECTRONIC COMPONENT 東京応化工業株式会社 2021-07-01 WO disclosed
EP-1733211-B1 PROCESSABLE MOLECULARLY IMPRINTED POLYMERS UNIV JOHNS HOPKINS (US) 2012-01-11 EP disclosed
US-7678870-B2 Processable molecularly imprinted polymers THE JOHNS HOPKINS UNIVERSITY (US) 2010-03-16 US disclosed
US-20070197746-A1 Processable molecularly imprinted polymers THE JOHNS HOPKINS UNIVERSITY 2007-08-23 US disclosed
EP-1733211-A4 PROCESSABLE MOLECULARLY IMPRINTED POLYMERS UNIV JOHNS HOPKINS (US) 2007-05-30 EP disclosed
EP-1733211-A1 PROCESSABLE MOLECULARLY IMPRINTED POLYMERS THE JOHNS-HOPKINS UNIVERSITY (US) 2006-12-20 EP disclosed
US-7067702-B2 Process for preparing vinyl substituted beta-diketones THE JOHNS HOPKINS UNIVERSITY (US) 2006-06-27 US disclosed
US-20060069288-A1 Process for preparing vinyl substituted beta-diketones THE JOHNS HOPKINS UNIVERSITY 2006-03-30 US disclosed
WO-2005103655-A1 PROCESSABLE MOLECULARLY IMPRINTED POLYMERS THE JOHNS HOPKINS UNIVERSITY (US) 2005-11-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060069288-A1 Process for preparing vinyl substituted beta-diketones VRK1, VRK2, DEK MEN1 2957/4885HPGD 1787/4885KMT2A 1338/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.